5.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché OM Giù?
Forum
Previsione
Precedente Chiudi:
$5.40
Aprire:
$5.37
Volume 24 ore:
84,030
Relative Volume:
0.09
Capitalizzazione di mercato:
$93.13M
Reddito:
$114.73M
Utile/perdita netta:
$-140.94M
Rapporto P/E:
-1.8623
EPS:
-2.76
Flusso di cassa netto:
$-126.18M
1 W Prestazione:
-3.21%
1M Prestazione:
+54.52%
6M Prestazione:
-73.61%
1 anno Prestazione:
-60.23%
Outset Medical Inc Stock (OM) Company Profile
Nome
Outset Medical Inc
Settore
Industria
Telefono
669-231-8200
Indirizzo
3052 ORCHARD DRIVE, SAN JOSE
Confronta OM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
OM
Outset Medical Inc
|
5.13 | 98.03M | 114.73M | -140.94M | -126.18M | -2.76 |
|
ABT
Abbott Laboratories
|
107.84 | 188.86B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.31 | 135.38B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
352.87 | 137.16B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.68 | 129.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.87 | 49.00B | 5.88B | 1.34B | 799.60M | 2.3489 |
Outset Medical Inc Stock (OM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-08 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-06-21 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-04-08 | Iniziato | BTIG Research | Buy |
| 2024-04-05 | Aggiornamento | CL King | Neutral → Buy |
| 2024-01-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-13 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-17 | Iniziato | CL King | Neutral |
| 2022-11-11 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-07-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-08-18 | Iniziato | Cowen | Outperform |
| 2021-04-19 | Iniziato | Wells Fargo | Overweight |
| 2020-12-16 | Iniziato | Oppenheimer | Perform |
| 2020-10-12 | Iniziato | Barclays | Overweight |
| 2020-10-12 | Iniziato | BofA Securities | Buy |
| 2020-10-12 | Iniziato | Goldman | Buy |
| 2020-10-12 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-10-12 | Iniziato | SVB Leerink | Mkt Perform |
| 2020-10-12 | Iniziato | Stifel | Buy |
Mostra tutto
Outset Medical Inc Borsa (OM) Ultime notizie
Don't Ignore The Insider Selling In Outset Medical - simplywall.st
Outset Medical chair and CEO Trigg sells $71k in stock - Investing.com Australia
Outset Medical (NASDAQ:OM) EVP Marc Nash Sells 5,375 Shares - MarketBeat
Outset Medical (NASDAQ:OM) General Counsel Sells $47,687.68 in Stock - MarketBeat
Leslie Trigg Sells 2,120 Shares of Outset Medical (NASDAQ:OM) Stock - MarketBeat
Insider Selling: Outset Medical (NASDAQ:OM) CEO Sells 11,794 Shares of Stock - MarketBeat
Aug Opening: What is Outset Medical Incs 5 year growth outlookWall Street Watch & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Outset Medical (OM) soars 22.2%: Is further upside left in the stock? - MSN
Published on: 2026-01-14 00:30:41 - Bộ Nội Vụ
San Jose-based Outset Medical revenue up 5% to USD 119.5M in FY 2025 - Medical Buyer
Outset Medical (OM) Soars 22.2%: Is Further Upside Left in the Stock? - Yahoo Finance
Outset Medical reports 5% revenue growth in 2025, names new director - Investing.com Nigeria
Outset Medical stock beats Q4 sales estimates, reaches high end of 2025 guidance By Investing.com - Investing.com South Africa
Outset Medical stock beats Q4 sales estimates, reaches high end of 2025 guidance - Investing.com Australia
Outset Medical Gears Up for J.P. Morgan Healthcare Conference Buckle Up for Exciting Updates! - StocksToTrade
Stifel on Outset Medical Inc. (OM): 'Overall Solid 2025 Finish As Preliminary 4Q25 Sales Beat Consensus' - StreetInsider
Outset Medical reports 5% revenue growth in 2025, names new director By Investing.com - Investing.com South Africa
Outset Medical (OM) Poised for Growth with New Innovations - GuruFocus
Outset Medical Jumps As FY2025 Revenue Rebounds After Prior-Year Decline - Nasdaq
Outset Medical Shines with Dialysis Tech at JP Morgan Healthcare Conference - timothysykes.com
Outset Medical Previews 2025 Results and Adds Director - TipRanks
Outset Medical posts 5% revenue growth, adds board member - StreetInsider
Outset Medical Reports Unaudited Fourth Quarter and 2025 Results - marketscreener.com
Star TribuneOutset Medical Reports Unaudited Fourth Quarter and 2025 Results - FinancialContent
Will Outset Medical Inc. stock see insider buyingJuly 2025 Closing Moves & Free Fast Gain Swing Trade Alerts - ulpravda.ru
How Outset Medical Inc. stock compares to market leadersModel Comparison & stability guidance for smoother miles - Улправда
Nash, evp, sells Outset Medical (OM) shares worth $461 By Investing.com - Investing.com India
Is Outset Medical Inc. stock cheap compared to fundamentals2025 Biggest Moves & Low Drawdown Trading Techniques - Улправда
Outset Medical general counsel Brottem sells $956 in stock By Investing.com - Investing.com South Africa
Outset Medical general counsel Brottem sells $956 in stock - Investing.com
Nash, evp, sells Outset Medical (OM) shares worth $461 - Investing.com
Why analysts remain bullish on Outset Medical Inc. stock2025 Year in Review & Smart Investment Allocation Insights - Улправда
Is Outset Medical Inc. stock attractive for ETFsJuly 2025 Momentum & Community Driven Trade Alerts - Улправда
Stifel lowers Outset Medical stock price target to $8 from $14 By Investing.com - Investing.com South Africa
Stifel lowers Outset Medical stock price target to $8 from $14 - Investing.com Australia
Stifel Lowers Price Target for Outset Medical (OM) to $8.00 | OM Stock News - GuruFocus
Buy Signal: Will Outset Medical Inc stock deliver shareholder value2025 Year in Review & Fast Gaining Stock Reports - Bộ Nội Vụ
Outset Medical Inc. (OM) PT Lowered to $8 at Stifel - StreetInsider
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset ... - bdtonline.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc.OM - Chartmill
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - FinancialContent
Outset Medical, Inc. Announces Presentation at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Outset Medical to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-01-01 | Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NDAQ:OM | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Encourages Outset Medical, Inc. (OM) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Outset Medical, Inc. (NASDAQ:OM) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Outset Medical Inc Azioni (OM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):